An integrated approach to the study of Chlamydia trachomatis infection of the female genital tract
- PMID: 16683048
An integrated approach to the study of Chlamydia trachomatis infection of the female genital tract
Abstract
The two major aims of this thesis were firstly, to provide a basis for an integrated approach to study the oculogenital biovar of Chlamydia trachomatis in order to explain the complex and varied course of female genital tract infection; and secondly, to use the understanding gained through this approach to suggest possible intervention strategies. To accomplish this end, the projects conducted and reported upon in the thesis fall into four categorical sections. Part I of the thesis addresses the bacterial factors that contribute to the pathogenesis of infection using both in vitro observations and an in vivo experimental murine model. In Part II, host immunogenetic factors are analyzed using gene knockout mice and single nucleotide polymorphism (SNP) analysis of human genes. In Part III, the efficacy of prophylactic intervention on the susceptibility and course of female genital tract infection with C. trachomatis in the mouse is evaluated. Finally, in Part IV, the natural immune response to the pathogen and the relationship that these responses have on conferring protection and/or contributing to the pathology of disease are investigated to bring us closer to the ultimate protective intervention strategy: a vaccine against C. trachomatis. This article summarizes the aims and results of the thesis, followed by a general discussion and conclusions.
Similar articles
-
Identification of candidate genes using the murine model of female genital tract infection with Chlamydia trachomatis.Drugs Today (Barc). 2009 Nov;45 Suppl B:51-9. Drugs Today (Barc). 2009. PMID: 20011695 Review.
-
Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.J Microbiol Immunol Infect. 2005 Dec;38(6):383-93. J Microbiol Immunol Infect. 2005. PMID: 16341338
-
Description of the ICTI consortium: an integrated approach to the study of Chlamydia trachomatis infection.Drugs Today (Barc). 2006 Mar;42 Suppl A:107-14. Drugs Today (Barc). 2006. PMID: 16683050 Review.
-
Animal models for the study of Chlamydia trachomatis infections in the female genital infection.Drugs Today (Barc). 2006 Mar;42 Suppl A:55-63. Drugs Today (Barc). 2006. PMID: 16683045 Review.
-
Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection.Infect Immun. 2005 Dec;73(12):8317-21. doi: 10.1128/IAI.73.12.8317-8321.2005. Infect Immun. 2005. PMID: 16299329 Free PMC article.
Cited by
-
CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract.Drugs Today (Barc). 2009 Nov;45 Suppl B(Suppl B):125-34. Drugs Today (Barc). 2009. PMID: 20011704 Free PMC article.